Swedish Orphan, Under Pressure At Home, Looks to Commerical Swap With China Company For Growth
This article was originally published in PharmAsia News
Executive Summary
Swedish Orphan Biovitrum AB and partner Dongbao Enterprise Group Co.. have identified intravenous iron for anemia as the first product to be included in their previously announced commercial alliance. The move comes as SOBI ended its deal to distribute Amgen's Mimpara (cinacalcet) in the Nordic territories, the second time it has returned Scandinavian marketing rights to a partner in the past three months